CLDN5 and stroke disorder: In comparison to the Veh stroke brains, ZT-1a-treated stroke brains, but not the BMT-treated, exhibited statistically significant preservation of Claudin-5 protein expression in the ChP (Fig. 3a and b, p < 0.05).